Prospective Evaluation of the Predictive Value of PET in Patients With Diffuse Large B-cell-lymphoma Under R-CHOP-14. A Multicenter Study
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Cyclophosphamide (Primary) ; Doxorubicin (Primary) ; Prednisone (Primary) ; Rituximab (Primary) ; Vincristine (Primary)
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 01 Dec 2020 Results of post-hoc analysis published in the Hematological Oncology.
- 21 Jun 2020 Results presented at the 25th Congress of the European Haematology Association
- 02 Jul 2012 Planned end date changed from 1 Jun 2011 to 1 Sep 2015 as reported by ClinicalTrials.gov.